Epigenetic and Genetic Keys to Fight HPV-Related Cancers.
cancer
combinatorial therapies
epigenetic regulation
human papillomavirus
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Nov 2023
25 Nov 2023
Historique:
received:
23
10
2023
revised:
13
11
2023
accepted:
22
11
2023
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
9
12
2023
Statut:
epublish
Résumé
Cervical cancer ranks as the fourth most prevalent cancer among women globally, with approximately 600,000 new cases being diagnosed each year. The principal driver of cervical cancer is the human papillomavirus (HPV), where viral oncoproteins E6 and E7 undertake the role of driving its carcinogenic potential. Despite extensive investigative efforts, numerous facets concerning HPV infection, replication, and pathogenesis remain shrouded in uncertainty. The virus operates through a variety of epigenetic mechanisms, and the epigenetic signature of HPV-related tumors is a major bottleneck in our understanding of the disease. Recent investigations have unveiled the capacity of viral oncoproteins to influence epigenetic changes within HPV-related tumors, and conversely, these tumors exert an influence on the surrounding epigenetic landscape. Given the escalating occurrence of HPV-triggered tumors and the deficiency of efficacious treatments, substantial challenges emerge. A promising avenue to address this challenge lies in epigenetic modulators. This review aggregates and dissects potential epigenetic modulators capable of combatting HPV-associated infections and diseases. By delving into these modulators, novel avenues for therapeutic interventions against HPV-linked cancers have come to the fore.
Identifiants
pubmed: 38067286
pii: cancers15235583
doi: 10.3390/cancers15235583
pmc: PMC10705756
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Cell Biochem. 2019 Aug;120(8):12796-12802
pubmed: 30861164
Cancer Discov. 2021 Sep;11(9):2248-2265
pubmed: 33837065
Expert Opin Investig Drugs. 2008 Jul;17(7):1051-65
pubmed: 18549341
Int J Mol Sci. 2023 Mar 27;24(7):
pubmed: 37047272
Adv Exp Med Biol. 2016;945:151-172
pubmed: 27826838
Cell Death Differ. 2022 May;29(5):946-960
pubmed: 35361964
Annu Rev Virol. 2015 Nov;2(1):403-23
pubmed: 26958922
Clin Sci (Lond). 2017 Aug 10;131(17):2201-2221
pubmed: 28798073
Rev Med Virol. 2015 Mar;25 Suppl 1:2-23
pubmed: 25752814
Epigenetics. 2008 Nov;3(6):300-9
pubmed: 19029799
Front Microbiol. 2020 Jan 21;10:3116
pubmed: 32038557
Virol J. 2016 Jan 04;13:2
pubmed: 26728921
Chem Biol Drug Des. 2016 Oct;88(4):574-84
pubmed: 27235003
Hum Pathol. 1992 Feb;23(2):117-28
pubmed: 1310950
Sci Rep. 2017 Dec 7;7(1):17113
pubmed: 29215041
Int J Mol Sci. 2021 Feb 23;22(4):
pubmed: 33672181
J Virol. 2006 May;80(9):4580-90
pubmed: 16611918
PLoS One. 2009;4(3):e5018
pubmed: 19325708
Cancers (Basel). 2020 Jul 17;12(7):
pubmed: 32708897
Int J Mol Sci. 2022 Apr 29;23(9):
pubmed: 35563334
Biomed Pharmacother. 2022 Apr;148:112743
pubmed: 35228065
Pathogens. 2021 Jun 19;10(6):
pubmed: 34205361
Sci Rep. 2015 Jul 08;5:11724
pubmed: 26152361
Crit Rev Oncol Hematol. 2022 Oct;178:103778
pubmed: 35932993
Cancer Res. 2018 Mar 15;78(6):1418-1430
pubmed: 29339538
J Virol. 2013 Mar;87(6):3435-46
pubmed: 23302890
J Oral Pathol Med. 2020 Sep;49(8):771-779
pubmed: 32450006
Cell Cycle. 2005 Nov;4(11):1608-15
pubmed: 16222116
Biomed Pharmacother. 2016 Oct;83:450-455
pubmed: 27427851
Clinics (Sao Paulo). 2018 Oct 11;73(suppl 1):e486s
pubmed: 30328948
PLoS Pathog. 2017 May 2;13(5):e1006200
pubmed: 28463988
Int J Mol Sci. 2018 Jun 08;19(6):
pubmed: 29890655
Front Bioeng Biotechnol. 2022 Jun 22;10:797440
pubmed: 35814023
Virology. 2010 Jul 20;403(1):1-16
pubmed: 20441998
Viruses. 2021 Nov 06;13(11):
pubmed: 34835040
Med J Islam Repub Iran. 2021 May 22;35:65
pubmed: 34277502
Infect Agent Cancer. 2023 Feb 26;18(1):13
pubmed: 36843070
Vaccine. 2012 Nov 20;30 Suppl 5:F83-7
pubmed: 23199968
Cancers (Basel). 2016 Oct 19;8(10):
pubmed: 27775564
Virology. 2021 Feb;554:9-16
pubmed: 33321328
PLoS One. 2013 Oct 02;8(10):e75406
pubmed: 24098381
Oncol Lett. 2022 Aug 25;24(4):358
pubmed: 36168313
Front Immunol. 2020 Feb 18;11:188
pubmed: 32133000
J Biol Chem. 1997 Mar 28;272(13):8236-42
pubmed: 9079642
Cancers (Basel). 2023 Feb 13;15(4):
pubmed: 36831533
Genomics Proteomics Bioinformatics. 2022 Jul 11;:
pubmed: 35835441
Cancers (Basel). 2023 Aug 21;15(16):
pubmed: 37627216
J Virol. 2013 May;87(10):6037-43
pubmed: 23468503
Virus Res. 2017 Mar 2;231:83-95
pubmed: 27867028
Virology. 2013 Oct;445(1-2):138-68
pubmed: 23731972
Viruses. 2015 Jul 16;7(7):3863-90
pubmed: 26193301
Mol Diagn Ther. 2018 Aug;22(4):421-430
pubmed: 29777397
Oncogene. 2016 Sep 8;35(36):4773-86
pubmed: 26876196
Acta Cytol. 2020;64(5):420-424
pubmed: 32235115
Viruses. 2019 Apr 22;11(4):
pubmed: 31013597
J Gen Virol. 2011 Nov;92(Pt 11):2620-2627
pubmed: 21813705
Biomedicines. 2022 Jun 24;10(7):
pubmed: 35884798
Clin Cancer Res. 2017 Dec 1;23(23):7276-7287
pubmed: 28916527
Hum Mol Genet. 2022 Jun 22;31(12):2023-2034
pubmed: 35022732
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Virology. 2007 Nov 25;368(2):219-26
pubmed: 17675127
Eur J Med Chem. 2019 Feb 15;164:214-240
pubmed: 30594678
Asian Pac J Cancer Prev. ;18(2):315-319
pubmed: 28345325
Viruses. 2017 Sep 01;9(9):
pubmed: 28862667
Sci Rep. 2020 Aug 26;10(1):14195
pubmed: 32848167
EXCLI J. 2021 Feb 12;20:320-337
pubmed: 33746665
Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:36-50
pubmed: 28528689
Clin Cancer Res. 2009 Jan 15;15(2):570-7
pubmed: 19147762
J Virol. 2003 Dec;77(23):12450-9
pubmed: 14610169
Biosci Rep. 2019 Apr 12;39(4):
pubmed: 30886064
J Virol. 2012 Jan;86(1):348-57
pubmed: 22031941
Mol Cancer. 2011 Nov 11;10:140
pubmed: 22078316
J Virol. 2003 Dec;77(24):13125-35
pubmed: 14645569
Oncol Res. 2023 Feb 3;30(5):211-219
pubmed: 37305348
Front Oncol. 2019 May 08;9:355
pubmed: 31134154
Trends Microbiol. 2004 Dec;12(12):527-9
pubmed: 15539109
Int J Cancer. 2015 Jun 15;136(12):2752-60
pubmed: 25043222
Am J Health Syst Pharm. 2016 Apr 1;73(7):441-50
pubmed: 27001985
Nat Rev Mol Cell Biol. 2013 May;14(5):297-306
pubmed: 23594950
Cancer. 2017 Jun 15;123(12):2219-2229
pubmed: 28346680
Oncotarget. 2017 Jul 11;8(28):46163-46176
pubmed: 28521287
Cell Mol Immunol. 2021 Sep;18(9):2083-2100
pubmed: 34267335
Microorganisms. 2021 Oct 01;9(10):
pubmed: 34683397
Am J Pathol. 1994 Jan;144(1):141-7
pubmed: 8291603
Papillomavirus Res. 2018 Jun;5:172-179
pubmed: 29649654
J Med Virol. 2000 Feb;60(2):205-9
pubmed: 10596022
Proc Natl Acad Sci U S A. 2016 May 31;113(22):6289-94
pubmed: 27190090
Immunol Rev. 2019 Jul;290(1):127-147
pubmed: 31355495
J Virol. 1997 Mar;71(3):2449-56
pubmed: 9032382
Nat Rev Microbiol. 2013 Apr;11(4):239-51
pubmed: 23474685
Iran J Basic Med Sci. 2016 Jun;19(6):601-7
pubmed: 27482340
Front Biosci. 2006 Sep 01;11:2286-302
pubmed: 16720315
Front Immunol. 2023 Apr 26;14:1105265
pubmed: 37180106
Biochim Biophys Acta. 2008 Mar;1782(3):127-50
pubmed: 18201576
Trends Cell Biol. 2020 Aug;30(8):640-652
pubmed: 32513610
Pathogens. 2020 Jun 18;9(6):
pubmed: 32570816
Onderstepoort J Vet Res. 2015 Apr 16;82(1):858
pubmed: 26017637
J Clin Microbiol. 1999 Jul;37(7):2270-3
pubmed: 10364596
J Biol Chem. 1999 Feb 26;274(9):5810-22
pubmed: 10026203
Cell. 2007 Feb 23;128(4):683-92
pubmed: 17320506
Protein Sci. 2017 Jul;26(7):1266-1277
pubmed: 28329910
Int J Mol Sci. 2018 Apr 28;19(5):
pubmed: 29710796
Papillomavirus Res. 2018 Jun;5:46-58
pubmed: 29277575
Tumour Biol. 2015 Sep;36(10):7615-22
pubmed: 25921283
Virus Res. 2017 Mar 2;231:103-107
pubmed: 27840111
J Virol. 2021 Sep 9;95(19):e0068621
pubmed: 34232709
Int J Mol Sci. 2019 Mar 14;20(6):
pubmed: 30875794
Front Immunol. 2023 Jan 13;13:1068449
pubmed: 36713387
Front Behav Neurosci. 2016 Jun 10;10:107
pubmed: 27375447
Antivir Ther. 2013;18(3):271-83
pubmed: 23615820
Oncogene. 2020 Oct;39(40):6327-6339
pubmed: 32848210
Front Immunol. 2022 Mar 30;13:850358
pubmed: 35432319
Biomed Res Int. 2022 Sep 23;2022:9978571
pubmed: 36193328
Expert Rev Vaccines. 2014 Aug;13(8):1013-26
pubmed: 24965128
J Lipid Atheroscler. 2020 Sep;9(3):419-434
pubmed: 33024734
Traffic. 2014 Feb;15(2):127-40
pubmed: 24289861
Oncol Nurs Forum. 1985 Sep-Oct;12(5):66-7
pubmed: 3849793
J Histochem Cytochem. 2014 Jan;62(1):11-33
pubmed: 24051359
Epigenetics. 2019 Dec;14(12):1141-1163
pubmed: 31284823
J Obstet Gynaecol. 2020 Jul;40(5):602-608
pubmed: 31500479
Head Neck. 2016 Apr;38 Suppl 1:E694-704
pubmed: 25899179
mBio. 2021 Feb 16;12(1):
pubmed: 33593981
Virology. 2013 Oct;445(1-2):80-98
pubmed: 24016539
PLoS Pathog. 2019 Feb 25;15(2):e1007590
pubmed: 30802273
Int J Mol Sci. 2020 Nov 24;21(23):
pubmed: 33255318
Front Cell Infect Microbiol. 2021 Apr 30;11:649815
pubmed: 33996630
J Virol. 2004 Nov;78(22):12179-88
pubmed: 15507604
Oncol Lett. 2018 Jan;15(1):11-22
pubmed: 29285184
Acta Pharm Sin B. 2023 Jun;13(6):2425-2463
pubmed: 37425042
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11138-E11147
pubmed: 30385631
J Biol Chem. 2002 Jun 28;277(26):23958-64
pubmed: 11971900
Cell. 1992 Nov 27;71(5):865-73
pubmed: 1423634
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12180-4
pubmed: 1334560
Eur J Med Chem. 2018 Oct 5;158:620-706
pubmed: 30245394
Clinics (Sao Paulo). 2018 Sep 06;73(suppl 1):e539s
pubmed: 30208168
PLoS Pathog. 2018 Oct 12;14(10):e1007367
pubmed: 30312361
Genes Cancer. 2015 May;6(5-6):184-213
pubmed: 26124919
Virus Res. 2017 Mar 2;231:56-75
pubmed: 27818212
Elife. 2017 Mar 21;6:
pubmed: 28322723
Biomed Rep. 2021 Jul;15(1):60
pubmed: 34094536
Clin Epigenetics. 2017 Nov 28;9:124
pubmed: 29209433
Int J Mol Sci. 2021 Jul 06;22(14):
pubmed: 34298900
Mol Biol Rep. 2021 Dec;48(12):8075-8095
pubmed: 34671902
Front Biosci (Landmark Ed). 2022 Dec 20;27(12):326
pubmed: 36624943
Int J Mol Sci. 2022 Feb 05;23(3):
pubmed: 35163748
Oncogene. 2003 Sep 11;22(39):7871-81
pubmed: 12970734
Viruses. 2022 Dec 31;15(1):
pubmed: 36680181
Viruses. 2018 Jan 18;10(1):
pubmed: 29346309
Drug Discov Today. 2019 Oct;24(10):2044-2057
pubmed: 31398400
Biomedicines. 2023 Jan 16;11(1):
pubmed: 36672733
J Mol Biol. 1997 Jul 18;270(3):385-95
pubmed: 9237905
Nat Rev Immunol. 2020 Nov;20(11):651-668
pubmed: 32433532
Curr Biol. 1997 Sep 1;7(9):689-92
pubmed: 9285713
Biomark Res. 2017 Jun 24;5:22
pubmed: 28652918
J Oncol. 2019 Oct 10;2019:3257939
pubmed: 31687023
Microb Pathog. 2020 Feb;139:103923
pubmed: 31836496
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21573-21579
pubmed: 31591214
Oncogene. 2020 May;39(19):3939-3951
pubmed: 32203167
Br J Dermatol. 2003 Nov;149 Suppl 66:5-8
pubmed: 14616337
Biomed Rep. 2014 Sep;2(5):653-658
pubmed: 25054006
Mol Ther. 2019 Dec 4;27(12):2091-2099
pubmed: 31537455
JCI Insight. 2018 Apr 19;3(8):
pubmed: 29669936
Virol J. 2023 Jul 11;20(1):144
pubmed: 37434253
Front Genet. 2022 Jun 14;13:886613
pubmed: 35774512
Virology. 2013 Oct;445(1-2):175-86
pubmed: 23689062
Infect Disord Drug Targets. 2009 Apr;9(2):201-22
pubmed: 19275707
Science. 2010 Aug 6;329(5992):689-93
pubmed: 20616235
PLoS One. 2012;7(8):e43519
pubmed: 22927980
Front Cell Infect Microbiol. 2022 Jun 27;12:929666
pubmed: 35832386
Nat Immunol. 2002 Feb;3(2):196-200
pubmed: 11812998
Microbiol Spectr. 2022 Jun 29;10(3):e0150522
pubmed: 35608352
mBio. 2019 Mar 19;10(2):
pubmed: 30890607
Cancers (Basel). 2020 Dec 05;12(12):
pubmed: 33291485
J Virol. 2006 Sep;80(18):8940-50
pubmed: 16940506
J Gen Virol. 2021 Mar;102(3):
pubmed: 33427604
J Virol. 2006 Feb;80(4):1787-97
pubmed: 16439535
Sci Rep. 2019 Sep 20;9(1):13620
pubmed: 31541186
Antivir Ther. 2009;14(7):939-52
pubmed: 19918098
Front Immunol. 2023 Mar 07;14:1112513
pubmed: 36960048
Cold Spring Harb Perspect Biol. 2016 Apr 01;8(4):a019521
pubmed: 27037415
Front Microbiol. 2019 Oct 31;10:2483
pubmed: 31749782
PLoS Pathog. 2015 Sep 25;11(9):e1005181
pubmed: 26405826
Cancers (Basel). 2021 Jan 27;13(3):
pubmed: 33513914
Genome Biol Evol. 2019 Jun 1;11(6):1602-1617
pubmed: 31076746
Molecules. 2015 Mar 02;20(3):3898-941
pubmed: 25738536
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1522-7
pubmed: 16432208
Biomed Pharmacother. 2016 Dec;84:1393-1405
pubmed: 27802904
EMBO Rep. 2021 Jul 5;22(7):e52774
pubmed: 34159701
Cancer Lett. 2023 Jul 10;566:216242
pubmed: 37217069
J Virol. 2013 Jul;87(13):7502-15
pubmed: 23637395
Oncotarget. 2017 Oct 25;8(56):96323-96339
pubmed: 29221209
J Virol. 1977 Mar;21(3):1205-9
pubmed: 191643
Mol Cancer. 2012 Mar 26;11:17
pubmed: 22449259
Viruses. 2021 Sep 22;13(10):
pubmed: 34696321
Nucleic Acids Res. 1998 Feb 15;26(4):1038-45
pubmed: 9461465
J Immunother Cancer. 2021 Oct;9(10):
pubmed: 34706886
Viruses. 2021 Jul 17;13(7):
pubmed: 34372596
Environ Mol Mutagen. 2017 Jun;58(5):235-263
pubmed: 28485537
Cancers (Basel). 2022 Sep 16;14(18):
pubmed: 36139648
Int J Pept Protein Res. 1989 Jul;34(1):56-65
pubmed: 2793309
Viruses. 2018 Jun 12;10(6):
pubmed: 29895728
Front Cell Infect Microbiol. 2020 Jun 25;10:307
pubmed: 32670895
J Virol. 2003 Oct;77(19):10186-201
pubmed: 12970404
Int J Mol Sci. 2023 Mar 31;24(7):
pubmed: 37047526
Mol Cancer Res. 2021 Feb;19(2):167-179
pubmed: 33106372
J Clin Microbiol. 2013 Oct;51(10):3207-15
pubmed: 23863566
PLoS Pathog. 2012 Feb;8(2):e1002519
pubmed: 22346752
Biochem Biophys Res Commun. 2014 Aug 8;450(4):1422-6
pubmed: 25044113
Mol Cancer Res. 2018 Jan;16(1):90-102
pubmed: 28928286
J Virol. 2016 Sep 29;90(20):9138-52
pubmed: 27489271
Exp Mol Med. 2023 Jul;55(7):1357-1370
pubmed: 37394582
Front Oncol. 2020 Nov 27;10:581007
pubmed: 33330058
Expert Opin Pharmacother. 2004 Feb;5(2):427-38
pubmed: 14996638
Med Oncol. 2011 Dec;28 Suppl 1:S540-6
pubmed: 20931299
Front Immunol. 2022 Sep 28;13:1019115
pubmed: 36248810
Int J Mol Sci. 2017 Jul 01;18(7):
pubmed: 28671573
Biochem J. 1990 Jan 15;265(2):309-20
pubmed: 2405840
J Exp Clin Cancer Res. 2017 May 25;36(1):71
pubmed: 28545552
Nature. 1996 Dec 19-26;384(6610):641-3
pubmed: 8967953
Genes Dev. 2015 May 1;29(9):961-74
pubmed: 25917549
Curr Oncol Rep. 2023 May;25(5):479-489
pubmed: 36853475
J Biol Chem. 2004 Jun 25;279(26):27816-23
pubmed: 15105426
J Mol Biol. 2014 Dec 12;426(24):4030-4048
pubmed: 25451029
Expert Rev Vaccines. 2018 Dec;17(12):1085-1091
pubmed: 30495978
Adv Genet. 2010;70:27-56
pubmed: 20920744